BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37349627)

  • 1. Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma.
    Tao L; Wang Y; Shen Z; Cai J; Zheng J; Xia S; Lin Z; Wan Z; Qi H; Jin R; Wang L; Xu J; Liang X
    Hepatol Int; 2024 Feb; 18(1):91-107. PubMed ID: 37349627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production.
    Tang J; Wang R; Tang R; Gu P; Han J; Huang W
    Pathol Res Pract; 2022 Feb; 230():153732. PubMed ID: 34974242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
    Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
    Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
    Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
    Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
    Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
    Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
    Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
    Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting FOXO1.
    Cheng Z; Cheng N; Tang X; Yang F; Ma W; Yu Q; Tang H; Xiao Q; Lei Z
    Exp Cell Res; 2023 Oct; 431(1):113741. PubMed ID: 37549804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
    Sun ZP; Tan ZG; Peng C; Yi WM
    J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L; Jiang G; Lu J; Wang L
    Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
    Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
    Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
    BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis.
    Wen LJ; Yin JG; Wang YX; Liu K; Zhao JX
    Parasit Vectors; 2023 Dec; 16(1):465. PubMed ID: 38124152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
    Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
    J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.
    Sun J; Feng M; Zou H; Mao Y; Yu W
    Histol Histopathol; 2023 Oct; 38(10):1129-1143. PubMed ID: 36331285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
    Toshida K; Itoh S; Harada N; Morinaga A; Yugawa K; Tomiyama T; Kosai-Fujimoto Y; Tomino T; Kurihara T; Nagao Y; Morita K; Oda Y; Yoshizumi T
    Cancer Sci; 2023 Mar; 114(3):937-947. PubMed ID: 36369960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.